Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

250.21 -55.69 (-18.21%)
Streaming Delayed Price Updated: 10:42 AM EDT, May 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cencora, Inc. Common Stock

< Previous 1 2 Next >
News headline image
Cencora Reports Fiscal 2026 Second Quarter Results
From Cencora
Via Business Wire
News headline image
Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release
From Cencora
Via Business Wire
News headline image
Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business
From Cencora
Via Business Wire
News headline image
Cencora Announces Financial Leadership Transition
From Cencora
Via Business Wire
News headline image
Covetrus and MWI Animal Health to Merge
From Cencora
Via Business Wire
News headline image
Cencora Closes $3.0 Billion Senior Notes Offering
From Cencora
Via Business Wire
News headline image
Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056
From Cencora
Via Business Wire
News headline image
Cencora Reports Fiscal 2026 First Quarter Results
From Cencora
Via Business Wire
News headline image
Cencora Elects Ellen Cooper to Its Board of Directors
From Cencora
Via Business Wire
News headline image
Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release
From Cencora
Via Business Wire
News headline image
Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology
From Cencora
Via Business Wire
News headline image
Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results
From Cencora
Via Business Wire
News headline image
Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
News headline image
Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
From Cencora
Via Business Wire
News headline image
Cencora Reports Fiscal 2025 Third Quarter Results
From Cencora
Via Business Wire
News headline image
Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
News headline image
Cencora Elects Lori J. Ryerkerk to Its Board of Directors
From Cencora
Via Business Wire
News headline image
Cencora Reports Fiscal 2025 Second Quarter Results
From Cencora
Via Business Wire
News headline image
Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
News headline image
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
From Cencora
Via Business Wire
News headline image
Cencora Reports Fiscal 2025 First Quarter Results
From Cencora
Via Business Wire
News headline image
Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
News headline image
Cencora Completes Acquisition of Retina Consultants of America
From Cencora
Via Business Wire
News headline image
Cencora Closes $1.8 Billion Senior Notes Offering
From Cencora
Via Business Wire
News headline image
Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035
From Cencora
Via Business Wire
News headline image
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
From Cencora
Via Business Wire
News headline image
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
From Cencora
Via Business Wire
News headline image
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
From Cencora
Via Business Wire
News headline image
Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy
Walgreens Boots Alliance (WBA) is down 60% from its 52-week high, but improving earnings, cost cuts, and a 9.27% dividend yield signal potential recovery. 
Via MarketBeat
News headline image
Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
From Cencora
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.